All Stories

  1. A guide to conducting systematic reviews of clinical laboratory tests

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), August 2023, De Gruyter

    Dr Andrew C Don-Wauchope

  2. Assessment of the Measurement Error in Cyclosporine Levels Drawn Between Peripheral and Central Sources

    Article • American Journal of Clinical Pathology, December 2017, Oxford University Press (OUP)

    Dr Andrew C Don-Wauchope

  3. Point-of-care testing (POCT) and evidence-based laboratory medicine (EBLM) – does it leverage any advantage in clinical decision making?

    Article • Critical Reviews in Clinical Laboratory Sciences, November 2017, Taylor & Francis

    Dr Andrew C Don-Wauchope

  4. Rates of inappropriate laboratory test utilization in Ontario

    Article • Clinical Biochemistry, October 2017, Elsevier

    Dr Andrew C Don-Wauchope

  5. Evaluation of a chemiluminescent immunoassay for urinary aldosterone on the DiaSorin LIAISON automated platform against RIA and LC-MS/MS

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), July 2017, De Gruyter

    Dr Andrew C Don-Wauchope

  6. Commutable samples with assigned target concentrations may help us harmonise general chemistry results

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2017, De Gruyter

    Dr Andrew C Don-Wauchope

  7. Clinical implications of estrone sulfate measurement in laboratory medicine

    Article • Critical Reviews in Clinical Laboratory Sciences, December 2016, Taylor & Francis

    Dr Andrew C Don-Wauchope

  8. Lot change for reagents and calibrators

    Article • Clinical Biochemistry, November 2016, Elsevier

    Dr Andrew C Don-Wauchope

  9. Familial partial lipodystrophy presenting as metabolic syndrome

    Article • Journal of Clinical Lipidology, November 2016, Elsevier

    Dr Andrew C Don-Wauchope

  10. Frameshift mutation in the APOA5 gene causing hypertriglyceridemia in a Pakistani family: Management and considerations for cardiovascular risk

    Article • Journal of Clinical Lipidology, September 2016, Elsevier

    Dr Andrew C Don-Wauchope

  11. Acceptable Analytical Variation May Exceed High-Sensitivity Cardiac Troponin I Cutoffs in Early Rule-Out and Rule-In Acute Myocardial Infarction Algorithms

    Article • Clinical Chemistry, April 2016, AACC

    Dr Andrew C Don-Wauchope, pete kavsak

  12. Error detection in routine clinical chemistry laboratory test results

    Article • Clinical Biochemistry, February 2016, Elsevier

    Dr Andrew C Don-Wauchope

  13. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline

    Article • The Journal of Clinical Endocrinology & Metabolism, February 2016, Endocrine Society

    Dr Andrew C Don-Wauchope

  14. Evaluation of natriuretic peptide recommendations in heart failure clinical practice guidelines

    Article • Clinical Biochemistry, January 2016, Elsevier

    Dr Andrew C Don-Wauchope

  15. Successful reintroduction of statin therapy after statin-associated rhabdomyolysis

    Article • Journal of Clinical Lipidology, July 2015, Elsevier

    Dr Andrew C Don-Wauchope

  16. Laboratory challenges in primary aldosteronism screening and diagnosis

    Article • Clinical Biochemistry, April 2015, Elsevier

    Dr Andrew C Don-Wauchope

  17. Evidence based application of BNP/NT-proBNP testing in heart failure

    Article • Clinical Biochemistry, March 2015, Elsevier

    Dr Andrew C Don-Wauchope

  18. Assessing the long-term stability of total bilirubin protected from light under refrigerated conditions

    Article • Clinical Biochemistry, August 2014, Elsevier

    Dr Andrew C Don-Wauchope

  19. Reactivity of macroprolactin in two widely used commercial prolactin immunoassays

    Article • Clinical Biochemistry, August 2014, Elsevier

    Dr Andrew C Don-Wauchope

  20. The diagnostic role of B-type natriuretic peptide in pediatric populations: A systematic review

    Article • Clinical Biochemistry, August 2014, Elsevier

    Dr Andrew C Don-Wauchope

  21. Incremental predictive value of natriuretic peptides for prognosis in the chronic stable heart failure population: a systematic review

    Article • Heart Failure Reviews, August 2014, Springer Science + Business Media

    Dr Andrew C Don-Wauchope

  22. B-type natriuretic peptide-guided therapy: a systematic review

    Article • Heart Failure Reviews, July 2014, Springer Science + Business Media

    Dr Andrew C Don-Wauchope

  23. BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review

    Article • Heart Failure Reviews, July 2014, Springer Science + Business Media

    Dr Andrew C Don-Wauchope

  24. Incremental value of natriuretic peptide measurement in acute decompensated heart failure (ADHF): a systematic review

    Article • Heart Failure Reviews, July 2014, Springer Science + Business Media

    Dr Andrew C Don-Wauchope

  25. Prediction of clinical outcomes using B-type natriuretic peptides in the general population: a systematic review

    Article • Heart Failure Reviews, July 2014, Springer Science + Business Media

    Dr Andrew C Don-Wauchope

  26. BNP and NT-proBNP as prognostic markers in persons with chronic stable heart failure

    Article • Heart Failure Reviews, July 2014, Springer Science + Business Media

    Dr Andrew C Don-Wauchope

  27. Performance of BNP and NT-proBNP for diagnosis of heart failure in primary care patients: a systematic review

    Article • Heart Failure Reviews, June 2014, Springer Science + Business Media

    Dr Andrew C Don-Wauchope

  28. A systematic review of BNP and NT-proBNP in the management of heart failure: overview and methods

    Article • Heart Failure Reviews, June 2014, Springer Science + Business Media

    Dr Andrew C Don-Wauchope

  29. Use of BNP and NT-proBNP for the diagnosis of heart failure in the emergency department: a systematic review of the evidence

    Article • Heart Failure Reviews, June 2014, Springer Science + Business Media

    Dr Andrew C Don-Wauchope

  30. Dual Reporting of Hemoglobin A1C in the Canadian Journal of Diabetes

    Article • Canadian Journal of Diabetes, June 2014, Elsevier

    Dr Andrew C Don-Wauchope

  31. Within-run precision and outlier detection for the Abbott ARCHITECT cardiac troponin I assay

    Article • Annals of Clinical Biochemistry International Journal of Laboratory Medicine, May 2014, SAGE Publications

    Dr Andrew C Don-Wauchope

  32. Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials

    Article • European Journal of Clinical Nutrition, February 2014, Nature

    Dr Andrew C Don-Wauchope

  33. Assessing different population-based troponin T 99th percentiles for women in labor

    Article • Clinical Biochemistry, September 2012, Elsevier

    Dr Andrew C Don-Wauchope

  34. Lithium overdose associated acute thyrotoxicosis due to silent thyroiditis

    Article • Clinical Biochemistry, September 2012, Elsevier

    Dr Andrew C Don-Wauchope

  35. Position statement of the Canadian Society of Clinical Chemists and Canadian Association of Medical Biochemists on hemoglobin A1c measurement and reporting

    Article • Clinical Biochemistry, September 2012, Elsevier

    Dr Andrew C Don-Wauchope

  36. Applicability of the AGREE II Instrument in Evaluating the Development Process and Quality of Current National Academy of Clinical Biochemistry Guidelines

    Article • Clinical Chemistry, August 2012, AACC

    Dr Andrew C Don-Wauchope

  37. Reporting of post-polyethylene glycol prolactin: precipitation by polyethylene glycol 6000 or polyethylene glycol 8000 will change reference intervals for monomeric prolactin

    Article • Annals of Clinical Biochemistry International Journal of Laboratory Medicine, May 2012, SAGE Publications

    Dr Andrew C Don-Wauchope

  38. Missed follow-up opportunities using a two-step screening approach for gestational diabetes

    Article • Diabetes Research and Clinical Practice, May 2012, Elsevier

    Dr Andrew C Don-Wauchope

  39. Improving serological test ordering patterns for the diagnosis of celiac disease through clinical laboratory audit of practice

    Article • Clinical Biochemistry, April 2012, Elsevier

    Dr Andrew C Don-Wauchope

  40. Adverse metabolic effects of a hypercaloric, high-fat diet in rodents precede observable changes in body weight

    Article • Nutrition Research, September 2011, Elsevier

    Dr Andrew C Don-Wauchope

  41. Comparison of monomeric prolactin levels following macroprolactin precipitation by PEG6000 and PEG8000

    Article • Clinical Biochemistry, September 2011, Elsevier

    Dr Andrew C Don-Wauchope

  42. The Clinical Utility of Kidney Injury Molecule 1 in the Prediction, Diagnosis and Prognosis of Acute Kidney Injury: A Systematic Review

    Article • Inflammation & Allergy - Drug Targets, August 2011, Bentham Science Publishers

    Dr Andrew C Don-Wauchope

  43. Testing for Gluten-Related Disorders in Clinical Practice: The Role of Serology in Managing the Spectrum of Gluten Sensitivity

    Article • Canadian Journal of Gastroenterology, January 2011, Hindawi Publishing Corporation

    Dr Andrew C Don-Wauchope

  44. Pediatric critical values: Laboratory–pediatrician discourse

    Article • Clinical Biochemistry, November 2009, Elsevier

    Dr Andrew C Don-Wauchope

  45. The (mis) use of bone resorption markers in the context of bisphosphonate exposure, dental surgery and osteonecrosis of the jaw

    Article • Clinical Biochemistry, July 2009, Elsevier

    Dr Andrew C Don-Wauchope

  46. Bone turnover markers in the management of postmenopausal osteoporosis

    Article • Clinical Biochemistry, July 2009, Elsevier

    Dr Andrew C Don-Wauchope

  47. Laboratory defined critical value limits: How do hospital physicians perceive laboratory based critical values?

    Article • Clinical Biochemistry, June 2009, Elsevier

    Dr Andrew C Don-Wauchope

  48. Review of the prevalence of macroprolactinaemia in a South African hospital

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2009, De Gruyter

    Dr Andrew C Don-Wauchope

  49. Requesting and Interpreting Urine Albumin Measurements in the Primary Health Care Setting

    Article • Clinical Chemistry, August 2008, AACC

    Dr Andrew C Don-Wauchope

  50. Health in Africa: International experience may provoke animosity towards those returning home

    Article • BMJ, November 2005, BMJ

    Dr Andrew C Don-Wauchope

  51. Cortisol Responses to the Insulin Hypoglycaemia Test in Children

    Article • Hormone Research in Paediatrics, March 2004, Karger Publishers

    Dr Andrew C Don-Wauchope

  52. Clinical and radiological features of patients with macroprolactinaemia

    Article • Clinical Endocrinology, September 2003, Wiley

    Dr Andrew C Don-Wauchope

  53. Exocytosis Studies in a Chromaffin Cell-Free System

    Article • Annals of the New York Academy of Sciences, October 2002, Wiley

    Dr Andrew C Don-Wauchope

  54. High-efficiency Semliki Forest virus-mediated transduction in bovine adrenal chromaffin cells

    Article • Biochemical Journal, September 1999, Portland Press Ltd.

    Dr Andrew C Don-Wauchope

  55. High-efficiency Semliki Forest virus-mediated transduction in bovine adrenal chromaffin cells

    Article • Biochemical Journal, September 1999, Portland Press Ltd.

    Dr Andrew C Don-Wauchope